Scientists test cancer drug on bladder tumors before surgery
NCT ID NCT03837821
Summary
This study is testing a cancer drug called abemaciclib in bladder cancer patients who cannot receive standard chemotherapy. Twenty participants will take the drug for about a month before having their bladder surgically removed. Researchers will compare tumor samples taken before and after drug treatment to understand how the medication affects cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center - Simmons Comprehensive Cancer Center
Dallas, Texas, 75390, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.